Health Canada
- Status: approved
glargine basal insulin and glulisine prandial insulin (glargine basal insulin and glulisine prandial insulin) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Emory University is the originator. The local marketing authorisation holder may differ — check the official source linked above.